Cameco: The Operational Rock of the Uranium Market
The past few weeks have once again demonstrated why Cameco enjoys the status of an institutional heavyweight in the uranium industry. While the company returned to full production within a few days in May following a temporary flood-related shutdown, its solid quarterly figures underscored its operational resilience. Net income of CAD 131 million and adjusted EBITDA of CAD 509 million in the first quarter of 2026 are a clear sign that this operation delivers even under pressure. Management made it clear that the annual forecast of 19.5–21.5 million pounds of in-house production remains unchanged despite logistical hurdles. This is a testament to the robustness of the supply chains and the efficiency of the facilities in the Athabasca Basin, which ranks among the world’s best mining regions.
In parallel with its core operations, Cameco is strengthening its position in the industry’s most valuable assets. The agreement to increase its stake in the Cigar Lake Mine to approximately 57.4% is a strategic coup. For USD 115.75 million, the company is securing additional shares in a deposit with proven reserves of 172.4 million pounds, which is expected to remain in production through 2036. This acquisition demonstrates how Cameco consistently channels capital into the best deposits to capitalize on the rising demand for nuclear energy. The long-term contracts, with an average annual off-take volume of over 28 million pounds over the next five years, provide a level of planning certainty that is otherwise rarely found.
Cameco stands out from the competition primarily through its seamless control over the entire value chain. This encompasses uranium mining, fuel services and, not least, its involvement with Westinghouse. Added to this is the strategic partnership with the US government, which plans to co-finance the construction of up to ten new AP1000 reactors. The key drivers are a structural supply shortage that will not disappear overnight and the seemingly insatiable appetite for electricity among AI data centers. The valuation may seem ambitious at first glance, but Cameco serves as the benchmark for capital allocation across the entire nuclear sector. The stock is currently trading at around USD 103.47.
American Atomics: Building Critical Infrastructure
The US nuclear industry faces a fundamental dilemma. While the energy demands of data centers and AI infrastructure are projected to generate a 28% increase in uranium demand by 2030, domestic production is shrinking to a minimum. In 2023, the US produced just 50,000 pounds of yellowcake, while consumption stood at 32 million pounds. Dependence on Russian enrichment capacities, which still account for one-fifth of the required separation work, has raised red flags for the government in Washington. The Defence Production Act Fuel Cycle Consortium, of which American Atomics is a member, has long been coordinating the rebuilding of an independent supply chain. For investors, this presents a structural scarcity situation with political tailwinds.
American Atomics does not pursue a one-dimensional exploration approach. The company combines traditional uranium projects with technology development across the entire fuel cycle. Recent acquisitions, including the 100% acquisition of the Blue Streak project, with a mineral resource of just under 110,000 pounds of uranium, and the option on the promising Big Indian project in Utah, lay the foundation for the targeted milling capacity. The hub-and-spoke model, in collaboration with partner CVMR, aims to develop multiple deposits economically through a central processing plant. At the same time, the company is working to scale fuel-cycle technologies from the laboratory stage to pilot-plant readiness. Experience shows that this step can trigger significant increases in valuation.
With the appointment of Dr. Tomas J. Philipson, former Chair of the Council of Economic Advisers, to its Advisory Board, American Atomics underscores its commitment to actively shaping the political agenda. Direct involvement in DOE working groups provides access to expedited permitting processes and funding, such as for HALEU fuel, which will be essential for the next generation of reactors. While the public debate focuses on SMR manufacturers, American Atomics is addressing the actual bottleneck: the upstream supply chain. Long-term contract prices for uranium have been rising for years. This is a clear signal that the market has long since priced in the scarcity. Anyone building capacity here secures a strategic position with significant potential for value appreciation. The stock, currently trading at around CAD 0.24, has a new ticker symbol on the OTCQB Venture Market—NUKUF—previously GENMF.
Centrus Energy: Where Scarcity Meets Strategic Necessity
Centrus Energy’s stock is painting a mixed picture in 2026, oscillating between billion-dollar contracts and operational challenges. While the company is the only remaining domestic source of uranium enrichment in the US, it is grappling with high investment costs and a high market valuation. Centrus occupies a niche that is unlikely to lose significance in the coming years. The company possesses the only commercial enrichment technology of American origin and supplies both civilian nuclear power plants with low-enriched uranium (LEU) and new-generation reactors with HALEU fuel. This dual role as an energy and security provider gives Centrus a remarkable negotiating position. While other suppliers rely on global commodity markets, Centrus can count on long-term government procurement programs and growing commercial demand.
In the first quarter, revenue rose to USD 76.7 million, while net income fell to USD 10 million due to expansion-related costs. Analysts expect revenue of USD 450–500 million for the full year 2026, a forecast that management has recently raised. Criticism of the high valuation often overlooks the fact that Centrus is not yet in stable operations but is building a multi-billion-dollar infrastructure. Approximately USD 1.9 billion in cash and cash equivalents and an order backlog of USD 3.9 billion through 2040 provide a solid foundation for this transformation.
With Fluor, Palantir, and Geiger Brothers, Centrus has three strategic partners on board to accelerate the expansion of the facility in Piketon, Ohio. Initial cost savings of USD 300 million have already been identified. The real investment thesis, however, lies elsewhere. Centrus is benefiting from a structural imbalance. Demand for locally produced fuel is rising, while supply from Russia is increasingly exposed to political risks. This is precisely where pricing power arises. Investors willing to stick with the multi-year build-out process are betting on the restoration of American sovereignty in a critical area of energy infrastructure. The stock is currently trading at around USD 160.25.
The revaluation of the uranium sector is shifting value creation from mining to strategic processing. Cameco stands out as an operational heavyweight with seamless control over the entire value chain and stable margins. American Atomics addresses the actual bottleneck by rebuilding critical infrastructure with political tailwinds. Centrus Energy, in turn, occupies the niche of domestic enrichment and transforms strategic scarcity into pricing power.
Conflict of interest
Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as “Relevant Persons”) currently hold or hold shares or other financial instruments of the aforementioned companies and speculate on their price developments. In this respect, they intend to sell or acquire shares or other financial instruments of the companies (hereinafter each referred to as a “Transaction”). Transactions may thereby influence the respective price of the shares or other financial instruments of the Company.
In this respect, there is a concrete conflict of interest in the reporting on the companies.
In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.
For this reason, there is also a concrete conflict of interest.
The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.
Risk notice
Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.
The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.
The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.
Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein. For full disclaimer information, please click here.